VYOME HOLDINGS, INC. Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VYOME HOLDINGS, INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2022-06-30 was 143.54K shares.
- VYOME HOLDINGS, INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2022-03-31 was 765.65K shares.
- VYOME HOLDINGS, INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2021-06-30 was 0.00 shares.
- VYOME HOLDINGS, INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2021-03-31 was 0.00 shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2022-06-30 | 143.54K shares 10-Q · filed 2022-08-19 | |
| 2022-03-31 | 765.65K shares 10-Q · filed 2022-05-23 | |
| 2021-06-30 | 0.00 shares 10-Q · filed 2022-08-19 | |
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |